Examination of the clinical profiles of these genes in publicly available databases showed that expressions of some cytokines (SPP1, IL1A, IL1RN, OSM, CSF3, and TNFSF13B) were increased in primary tumors compared to normal tissues, suggesting interactions among immune cells, tumor cells, and other cells through cytokines during tumor development. The gene discussed is IL1A; the disease is neoplasm.